These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22795710)

  • 21. Paclitaxel-eluting balloon versus everolimus-eluting stent for treatment of drug-eluting stent restenosis.
    Almalla M; Schröder J; Pross V; Marx N; Hoffmann R
    Catheter Cardiovasc Interv; 2014 May; 83(6):881-7. PubMed ID: 23765557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Usefulness of minimum stent cross sectional area as a predictor of angiographic restenosis after primary percutaneous coronary intervention in acute myocardial infarction (from the HORIZONS-AMI Trial IVUS substudy).
    Choi SY; Maehara A; Cristea E; Witzenbichler B; Guagliumi G; Brodie B; Kellett MA; Dressler O; Lansky AJ; Parise H; Mehran R; Mintz GS; Stone GW
    Am J Cardiol; 2012 Feb; 109(4):455-60. PubMed ID: 22118823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benefits on coronary restenosis from elective paclitaxel-eluting stent implantation in patients aged 75 years and older.
    Sardella G; De Luca L; De Persio G; Colantonio R; Petrolini A; Conti G; Fedele F
    J Cardiovasc Med (Hagerstown); 2007 Jul; 8(7):494-8. PubMed ID: 17568281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: a randomized trial.
    Liistro F; Porto I; Angioli P; Grotti S; Ducci K; Falsini G; Bolognese L
    Am Heart J; 2013 Nov; 166(5):920-6. PubMed ID: 24176449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of scheduled angiographic follow-up in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Mindrescu C; Brener SJ; Guerchicoff A; Fahy M; Parise H; Mehran R; Stone GW
    J Interv Cardiol; 2013 Aug; 26(4):319-24. PubMed ID: 23795656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of cardiac rehabilitation on angiographic outcomes after drug-eluting stents in patients with de novo long coronary artery lesions.
    Lee JY; Yun SC; Ahn JM; Park DW; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Yoo YS; Park EK; Jin YS; Kim J; Nam HJ; Min SY; Park SJ
    Am J Cardiol; 2014 Jun; 113(12):1977-85. PubMed ID: 24795169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction.
    Dangas GD; Caixeta A; Mehran R; Parise H; Lansky AJ; Cristea E; Brodie BR; Witzenbichler B; Guagliumi G; Peruga JZ; Dudek D; Möeckel M; Stone GW;
    Circulation; 2011 Apr; 123(16):1745-56. PubMed ID: 21482968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Provisional stenting for multivessel PCI.
    Han B; Liu L; Aboud M; Nahir M; Hasin Y
    Int J Cardiovasc Intervent; 2005; 7(1):46-51. PubMed ID: 16019615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of nonfatal acute myocardial infarction late after stent implantation: the relative impact of disease progression, stent restenosis, and stent thrombosis.
    Alexopoulos D; Xanthopoulou I; Davlouros P; Damelou A; Mazarakis A; Chiladakis J; Hahalis G
    Am Heart J; 2010 Mar; 159(3):439-45. PubMed ID: 20211307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nine-month angiographic and 2-year clinical follow-up of the NOYA biodegradable polymer sirolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the NOYA I trial.
    Xu B; Dou K; Yang Y; Lv S; Wang L; Wang H; Li Z; Wang L; Chen Y; Huo Y; Li W; Kirtane AJ; Gao R
    EuroIntervention; 2012 Nov; 8(7):796-802. PubMed ID: 23171800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of chronic kidney disease on a re-percutaneous coronary intervention for sirolimus-eluting stent restenosis.
    Aoyama Y; Hirayama H; Ishii H; Kobayashi K; Ishikawa K; Takigawa M; Nanasato M; Yoshida Y; Aoyama T; Yoshikawa D; Matsubara T; Murohara T
    Coron Artery Dis; 2012 Dec; 23(8):528-32. PubMed ID: 22975841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of angiographic and IVUS follow-up between the two different drug-eluting stents implanted simultaneously in the same individuals.
    Xiang D; Yi S; Ruan Y; Gong Z; Hong C; Qiu J
    J Invasive Cardiol; 2012 Aug; 24(8):374-8. PubMed ID: 22865306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patency of paclitaxel-eluting versus bare metal stents long term after implantation in acute ST-segment elevation myocardial infarction.
    Vink MA; Van Nooijen FC; Laarman GJ; Suttorp MJ; Tijssen JG; Slagboom T; Patterson MS; Van Der Schaaf RJ; Kiemeneij F; Amoroso G; Dirksen MT
    Am J Cardiol; 2011 Nov; 108(9):1214-9. PubMed ID: 21864813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High high-density lipoprotein-cholesterol reduces risk and extent of percutaneous coronary intervention-related myocardial infarction and improves long-term outcome in patients undergoing elective percutaneous coronary intervention.
    Sattler KJ; Herrmann J; Yün S; Lehmann N; Wang Z; Heusch G; Sack S; Erbel R; Levkau B
    Eur Heart J; 2009 Aug; 30(15):1894-902. PubMed ID: 19474052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of atherothrombosis and vascular response to primary percutaneous coronary intervention in women versus men with acute myocardial infarction: results of the OCTAVIA study.
    Guagliumi G; Capodanno D; Saia F; Musumeci G; Tarantini G; Garbo R; Tumminello G; Sirbu V; Coccato M; Fineschi M; Trani C; De Benedictis M; Limbruno U; De Luca L; Niccoli G; Bezerra H; Ladich E; Costa M; Biondi Zoccai G; Virmani R;
    JACC Cardiovasc Interv; 2014 Sep; 7(9):958-68. PubMed ID: 25129664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of rehabilitation exercise on coronary artery after percutaneous coronary intervention in patients with coronary heart disease: a systematic review and meta-analysis.
    Fu C; Wang H; Wei Q; He C; Zhang C
    Disabil Rehabil; 2019 Dec; 41(24):2881-2887. PubMed ID: 29991296
    [No Abstract]   [Full Text] [Related]  

  • 37. Sirolimus-eluting stent versus paclitaxel-eluting stent for patients with long coronary artery disease.
    Kim YH; Park SW; Lee SW; Park DW; Yun SC; Lee CW; Hong MK; Kim HS; Ko JK; Park JH; Lee JH; Choi SW; Seong IW; Cho YH; Lee NH; Kim JH; Chun KJ; Park SJ;
    Circulation; 2006 Nov; 114(20):2148-53. PubMed ID: 17060388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sirolimus-eluting versus paclitaxel-eluting stents in diabetic and non-diabetic patients within sirolimus-eluting stent restenosis: results from the ISAR-DESIRE 2 trial.
    Kufner S; Byrne RA; de Waha A; Schulz S; Joner M; Laugwitz KL; Kastrati A;
    Cardiovasc Revasc Med; 2014 Mar; 15(2):69-75. PubMed ID: 24684757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracoronary infusion of progenitor cells is not associated with aggravated restenosis development or atherosclerotic disease progression in patients with acute myocardial infarction.
    Assmus B; Walter DH; Lehmann R; Honold J; Martin H; Dimmeler S; Zeiher AM; Schächinger V
    Eur Heart J; 2006 Dec; 27(24):2989-95. PubMed ID: 17053006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First-in-man study evaluating the safety and efficacy of a second generation biodegradable polymer sirolimus-eluting stent in the treatment of patients with de novo coronary lesions: clinical, Angiographic, and OCT outcomes of CREDIT-1.
    Wang G; Sun Z; Jin Q; Xu K; Li Y; Wang X; Ma Y; Liu H; Zhao X; Wang B; Deng J; Guan S; Ge M; Wang X; Xu B; Han Y
    Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():744-51. PubMed ID: 25630447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.